#Fiasp – Faster Acting, but what else is going on?
Having used Fiasp for nearly three weeks now, I’ve seen a couple of aspects to the insulin that have had me slightly mystified, and digging back […]
Articles by admin
#Fiasp and #OpenAPS – is this what we’ve been waiting for? A week in the life….
I’ll cut to the chase. This has been one of the more interesting weeks in my life with diabetes. There aren’t many occasions when you […]
So… How fast is Fiasp really? Well let’s take a look.
When I posted my first 48 hour review, less than 24 hours ago, I mentioned this graph, which suggested that it starts to take effect […]
48 hours with Fiasp. What are my first thoughts on Faster insulin Aspart?
If you follow social media, you’ll be aware that Novo Nordisk’s Faster Insulin Aspart (brand name Fiasp) became available earlier this year, having passed its […]
Are we living in the past? Good reasons why achieving the NICE Target Hba1C with the available NHS tools is tough…
As many people (but let’s face it, not all) are aware, the NICE target for Hba1C level is 6.5% as this is the point at […]
What’s the best CGM solution? A simple question with a complex answer…
Over the past couple of months, I’ve seen this question asked multiple times on many fora. Facebook, email lists and forums have all seen people […]
Changes in hypo awareness. What can we learn from an unexpected benefit of the use of #OpenAPS and #Loop
As you might guess from the title, I’ve noticed some changes in my hypo awareness, and I think I’d say that they’re generally in a […]
Novo Nordisk FIAsp. Announced and with us shortly in the UK, + whatever happened to BC Lispro…? #fasterinsulinplease
The first of the faster insulins that we saw a great deal of detail about at EASD 2016 is due to arrive at wholesalers near […]
Analyzing the output of the continuous monitoring survey – some thoughts on the data… #wearenotwaiting
Earlier this week I published the first set of results of the survey of CGM and Libre users that I undertook last year. There was […]
#ATTD2017 is over and it seems that the more things change, the more they stay the same… which is why #wearenotwaiting
The 10th international conference on Advanced Technologies and Treatments for Diabetes (ATTD) has come to a close and once more the twitter feed has been […]